Search
Palisade Bio Inc
PALIAdd to Watchlist
1.130USD
-0.030-2.59%
Close 11-06 16:00（ET）
196.93MMarket Cap
9.64P/E TTM
Palisade Bio Inc (PALI) Stock Price Target & Forecast
Analyst Rating
Based on 11 analysts giving stock ratings to Palisade Bio Inc in the past month.
Buy
4 Strong Buy
7 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
10.000USD+762.07%
PALI Analyst Recommendation Trends
In the current month, PALI has received 7 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. PALI average Analyst price target in the last month is 10.000.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
4
4
4
3
2
2
2
2
7
7
6
6
6
6
6
5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11
11
10
9
8
8
8
7
PALI Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
14
3
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
16
4
0
0
26
Insmed Inc
INSM
6
18
1
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
CRISPR Therapeutics AG
CRSP
4
8
11
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Biontech SE
BNTX
4
12
6
0
0
22
IQVIA Holdings Inc
IQV
8
13
1
0
0
22
Financial Forecasting
Based on analysts' estimates, PALI EPS is projected to reach -0.060 in FY2026Q3, following reported EPS of -0.050 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.08
-0.04
-0.05
-0.06
-0.07
Actual
-0.16
-0.05
-0.05
--
--
Surprise
-96.64%
-6.84%
+4.21%
--
--
FAQs
What is Palisade Bio Inc's price target?
Analysts forecast that Palisade Bio Inc's price target is USD 10.00, with the highest forecast at USD 25.00 and the lowest forecast at USD 5.00.
How have Palisade Bio IncPALI's recent earnings per share performed?
The market expectation was USD -0.05, while Palisade Bio IncPALI's earnings per share (EPS) for the previous quarter was USD -0.05. EPS for the next quarter is expected at USD -0.06.
What is the analyst rating for Palisade Bio Inc?
Based on the ratings of Palisade Bio Inc's stock from 11 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.